
Here is what is recommended for fluid intake and dietary changes.

Here is what is recommended for fluid intake and dietary changes.

The trend persists even after adjusting for surgical volume and experience.

Jury apportions fault among the plaintiff as well as the defendants.

Leuprolide acetate remains the most commonly used androgen suppression drug.

“This study represents the most comprehensive analysis to date of tumor mutation burden as a biomarker for response to immune checkpoint blockade,” according to lead study author Daniel J. McGrail, PhD.

Men with Peyronie’s disease have an increased risk of being diagnosed with a substance use disorder, anxiety disorder, depression, and self-injurious behaviors.

Medical necessity must be documented on the chart in order to bill code.

The technique is safer and more accurate than transrectal biopsy, an investigator says.

“I remember being, I guess, relieved that I matched. It’s so competitive. It’s never a sure thing. You match somewhere; I remember relief with that," says 1 urologist.

Investigational agents on the horizon include Vicineum, nadofaragene firadenovec, and N-803 (Anktiva).

PSA response rate was higher with the investigational radioligand therapy.

North American urologists analyzing outcomes from their initial experience treating urolithiasis with the high-power super pulse thulium fiber laser (Soltive) are encouraged by the results.

“The most important finding is that post-abiraterone, [bipolar androgen therapy] can markedly improve the magnitude and duration of response to enzalutamide,” the authors wrote.

The retrospective study compared reintervention rates in the 4 standard surgical interventions for lower urinary tract symptoms due to benign prostatic obstruction.

After adjusting for crossover using a preplanned sensitivity analysis, investigators for the pivotal phase 3 TITAN trial found a 48% reduction in the risk of death in patients treated with apalutamide plus ADT versus ADT alone.

Disease stage and adverse features were the main predictors of relapses and survival after robot-assisted radical cystectomy.